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1. Introduction 
Extracellular matrix and basement membranes 
contain collagens, proteoglycans and non-collagenous 
glycoproteins [ 11. Fibronectin is one of the glyco- 
proteins. It is present in the cell surface matrix of 
many cell types and mediates cell attachment [2]. 
Another high molecular weight, non-collagenous 
glycoprotein consisting of two polypeptides with 
mol. wt -200 000 and 400 000, has been found in 
the extracellular matrix elaborated by endodermal 
cells derived from mouse embryonal carcinoma [3,4]. 
A protein with a similar polypeptide composition and 
immunological crossreactivity with the endodermal 
cell protein has been isolated from a basement 
membrane-forming mouse tumor and has been 
named laminin [5]. The functional role of laminin 
is unknown, but the presence of this (or of immuno- 
logically similar) material in basement membranes 
[4-61 suggests that it could, as is thought to be the 
case with fibronectin, be involved in attachment of 
cells to basement membranes. 
The various extracellular matrix components, col- 
lagen, fibronectiqand glycosaminoglycans, interact 
with one another [7-l l] and such multiple inter- 
actions could be the basis for formation of extracel- 
lular matrix. Since laminin is also a matrix component, 
it was of interest to see whether it would interact 
with other components of the extracellular matrix. 
We show here that laminin from cultures of mouse 
endodermal cells interacts with heparin and heparan 
sulfate as evidenced by binding to heparinSepharose 
and inhibition of this binding. The interaction of 
laminin with glycosaminoglycans may be important 
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in the formation of basement membranes. Chroma- 
tography on heparin-Sepharose could be a useful 
step in the isolation of laminin. 
2. Materials and methods 
2.1. Isolation and identification of laminin 
The endodermal cell line PF HR-9 originally 
derived from the mouse endodermal carcinoma line 
PCC4-F [ 121 was used. The cell culture and the prep- 
aration of extracellular matrix were done as in [4]. 
The main glycoprotein of the matrix was extracted 
by incubating the isolated matrix in 0.5 M NaCl for 
48 h at 4°C. This protein is called laminin, based on 
earlier comparison of laminin and the glycoprotein of 
endodermal cell matrix [5] and results presented 
here. 
Antibodies to laminin were prepared by immu- 
nizing rabbits with laminin released from PF HR-9 
matrix by treatment with collagenase and with iso- 
lated 400 k component obtained by SDS gel electro- 
phoresis as in [6]. 
2.2. Affinity chromatography 
Heparin-Sepharose (Pharmacia Fine Chemicals, 
Uppbla), heat-denatured calf-skin collagen-Sepharose 
and fibronectin-Sepharose [ 131 were used. PF HR-9 
cells were seeded on bacteriological Petri dishes and 
labeled 7 days later with 20 $i [%]methionine or 
10 /Xi [ 3H]glucosamine per 10 ml culture medium for 
6 h. After labeling, the media were dialyzed against 
phosphate-buffered saline (PBS) [0.137 M NaCl, 
0.008 M Na2HP04, 0.015 M KH,P04, pH 7.41 and 
passed through a column of Sepharose 4B to elimi- 
nate possible components binding to Sepharose [ 131. 
The material that did not bind to Sepharose was then 
applied to a heparin (calf-skin colIagen, fibronectin)- 
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Sepharose column using 20 ml medium~~ gel. The 
columns were washed with PBS and eluted with 
increasing concentrations of NaCl in the above phos- 
phate buffer (heparin-Sepharose), or 8 M urea in 
0.05 M Tris-HCi buffer (pH 7.5) (collagen-Sepharose 
and fibronectin-Sepharose). 
2.3. Inhibition of binding of culture m dium proteins 
to pleparin-Sephr5se 
Dialyzed medium (70 000 cpm, 0.1 ml) from cul- 
tures labeled with [3H]glucosamine was incubated 
with 0.1 ml 50% suspension of hepar~-Sepharose 
with or without added soluble heparin (Sigma 
Chemical Co., St Louis, MO) or heparan sulfate 
(a gift from Upjohn Company, Kalamazoo, MI) in 
duplicate tubes. After incubation for 16 h at room 
temperature with shaking, the particles were washed 
4 times with 2 ml PBS and the bound material was 
eluted with 0.5 ml 0.5 M NaCl and radioactivity was 
measured. 
2.4. Eiectrophoresis and fluorography 
SDS-Polyacrylamide slab gel electrophoresis was 
done as in (141 using 5% acrylamide with 3.75% 
stacking els. Fluorography was performed according 
to [ 151. Myosin (mol. wt 200 000, Sigma) and fibro- 
nectin (monomer mol. wt 220 000; dimer mol. wt 
440 000) were used as molecular weight markers. 
2 ..5 . Immunoprecipitation 
Precipitation of proteins with antibodies and sub- 
sequent gel analysis was carried out using staphylo- 
cocci (Pansorbin, Calbiochem, La Jolla, CA) to isolate 
the immune complexes as in [ 161. 
3. Results 
When culture medium from PF HR-9 cells, labeled 
metabolically with [3H]glucosamine or [35S]methio- 
nine, was fractionated on heparin-Sepharose, -10% 
of the non-dialyzable radioactivity was bound to the 
column. The bound material eluted at high concen- 
trations of NaCl as a peak (frg.1). No significant 
radioactivity from media of labeled PF HR-9 cells 
bound to insolubilized calf-skin collagen or fibro- 
nectin. The bound and eluted fractions were found 
to contain the immunoreactive laminin present in the 
original culture medium. This was shown by immuno- 
diffusion against our anti-laminm which showed an 
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Fig.1. Affmity chromato~aphy of culture medium from 
PF HR-9 cells labeled with [35S]methionine on: (A) heparm- 
Sepharose; (B) collagen-Sepharose; (C) fibronectin- 
Sepharose. 
Fig.2. Imm~od~fu~on analaysis. Left: (a) Iaminiu isolated 
from the matrix of PF HR-9 cells; (b) original culture 
medium sample from PF HR.9 cells fractionated on heparin- 
Sepharose; (c) bound and eluted fraction from heparin- 
Sepharose; (d) non-bound fraction from heparin-Sepharose. 
The samples in (b,d) were concentrated IO-fold prior to 
analysis. Center well: antiserum to laminin from PF HR-9 
cells. Right: (a) Laminin from PF HR.9 cells; (b) and refer- 
ence laminin tested against (1) antiserum to lammln from 
PF HR-9 cells and (2) reference anti-laminm. 
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identical reactivity to reference anti-laminin provided 
by Dr George Martin, National Institute of Dental 
Research (Bethesda, MD) (fig.2). SDS-polyacryl- 
amide gel electrophoresis howed that the heparin- 
bound material contained non-radioactive proteins 
originating from the fetal bovine serum and, in addi- 
tion, two polypeptides (fig.3A,l) which had incor- 
porated radioactivity (fig.3B). These polypeptides 
migrated with the same mobility as reference laminin. 
The binding to heparin-Sepharose of the radioactiv- 
ity associated with these polypeptides was inhibited 
by soluble heparin and heparan sulfate (table 1). 
Table 1 
Inhibition of binding of laminin to heparin-Sepharose by 
heparin and heparan sulfate 
Concentration 
of inhibitor 
Radioactivity 
bound (cpm/tube) 
Inhibition 
(%) 
Control without 
inhibitor 
Heparin 
1 .O mg/ml 
2 .O mg/ml 
4 .O mg/ml 
Heparan sulfate 
2.0 mg/ml 
62 800 
29 400 53 
20 600 61 
9000 86 
62 500 1 
4 .O m&ml 44 800 29 
8.0 mg/ml 42 600 32 
4. Discussion 
Our results demonstrate that the major non- collagenous polypeptide components of extracellular 
matrix from endodermal cells bind to heparin. That 
these are the polypeptides of laminin is shown by 
the similarity of their molecular weights with authen- 
tic laminin, and the identical reactivities of our anti- 
sera and antisera to laminin. 
Fig.3. Heparin-Sepharose fractions of culture media from 
[“Slmethionine-labeled PF HR-9 cells analyzed in poly- 
acrylamide gel electrophoresis in the presence of SDS and 
2-mercaptoethanol. (A) Protein staining: (1) bound and 
eluted fraction; (2) non-bound fraction; (3) original culture 
media. The positions to which the polypeptides of reference 
laminin migrated are indicated by the arrows. (B) Fluorog- 
raphy of a gel similar to that in lane 1. 
The interaction of laminin with heparin shows a 
significant degree of specificity. Laminin was greatly 
enriched in the bound and eluted fraction relative to 
the fetal bovine serum proteins present in the culture 
medium and it was the only labeled protein released 
by the endodermal cells to the medium that showed 
such binding. Another indication of the specificity 
of the interaction with heparin-Sepharose is that 
laminin did not bind to plain Sepharose, fibronectin- 
Sepharose, or calf-skin collagen-Sepharose. The bind- 
ing to heparin could be reversed by increasing the salt 
concentration. It is interesting to note that extraction 
with salt also releases laminin from the insoluble matrix 
of the mouse tumor used in [5], as well as from the 
matrix of the endodermal cells used here. Since lam- 
inin interacts with heparan sulfate and heparan sulfate 
proteoglycan has been found to be a constituent of 
basement membranes [ 17,181 it seems that the inter- 
action of laminin with glycosaminoglycans we have 
demonstrated here could contribute to the structural 
integrity of basement membranes in vivo. 
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